The Use of Sentinel Node Biopsy to Upstage the Clinically N0 Neck in Head and Neck Cancer
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 128 (11) , 1287-1291
- https://doi.org/10.1001/archotol.128.11.1287
Abstract
A CONTINUING DEBATE in head and neck cancer is the management of the clinically N0 neck.1,2 Currently accepted management policies are that patients with a greater than 20% chance of subclinical metastases, based on the anatomic site and the size of the primary tumor, should undergo elective neck dissection (END).3-5 However, such a policy might still overtreat up to 80% of patients, and ENDs carry with them an associated morbidity.6-8Keywords
This publication has 14 references indexed in Scilit:
- The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinomaThe British Journal of Radiology, 2002
- The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neckCancer, 2001
- The Use of Clinical Criteria Alone in the Management of the Clinically Negative Neck Among Patients With Squamous Cell Carcinoma of the Oral Cavity and OropharynxJAMA Otolaryngology–Head & Neck Surgery, 2000
- Sensory Changes Associated With Selective Neck DissectionJAMA Otolaryngology–Head & Neck Surgery, 2000
- Sentinel Lymph Node Radiolocalization in Head and Neck Squamous Cell CarcinomaThe Laryngoscope, 2000
- Sentinel node biopsy for melanoma in the head and neck regionHead & Neck, 1999
- A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neckHead & Neck, 1999
- Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissectionHead & Neck, 1999
- Impact of Neck Dissection on Quality of LifeThe Laryngoscope, 1999
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992